BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 10072923)

  • 1. Inhibitory effects of copper-aspirin complex on platelet aggregation.
    Shen ZQ; Chen ZH; Ma GY; Wang DC; Wu WL; Liu WP; Yang YK; Xiong HZ
    Zhongguo Yao Li Xue Bao; 1997 Jul; 18(4):358-62. PubMed ID: 10072923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of magnesium lithospermate B on aggregation and 5-HT release in rabbit washed platelets.
    Wang W; Wang YP; Sun WK; Xu YM; Xuan LJ
    Acta Pharmacol Sin; 2000 Sep; 21(9):859-63. PubMed ID: 11501172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of thiofedrine on platelet aggregation, thromboxane B2 and 6-keto-PGF1 alpha in rats.
    Qu YZ; Wang YE; Li XX
    Methods Find Exp Clin Pharmacol; 1996 Jun; 18(5):297-300. PubMed ID: 8817463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of nimodipine on platelet aggregation and thrombosis.
    Ren YJ; Lü AG; Zhang GQ; Jia DH
    Zhongguo Yao Li Xue Bao; 1998 Mar; 19(2):158-60. PubMed ID: 10374642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of MN-9202 on platelet aggregation, 5-HT release, TXB2 synthesis, and calcium mobilization in rabbit platelets in vitro.
    Wang LL; Mei QB; Zhao DH; Guo ZA
    Acta Pharmacol Sin; 2000 Jul; 21(7):623-6. PubMed ID: 11360670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of berberine on platelet aggregation and plasma levels of TXB2 and 6-keto-PGF1 alpha in rats with reversible middle cerebral artery occlusion].
    Wu JF; Liu TP
    Yao Xue Xue Bao; 1995; 30(2):98-102. PubMed ID: 7785438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mepyramine inhibits platelet activating factor-induced rabbit platelet aggregation: role of intracellular histamine.
    Zeng S; Guo ZG
    Zhongguo Yao Li Xue Bao; 1997 Mar; 18(2):155-8. PubMed ID: 10072970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of procainamide on rabbit platelet aggregation and thromboxane B2 production in vitro.
    Shan CW; Lin JH; Jin YH
    Zhongguo Yao Li Xue Bao; 1998 Mar; 19(2):164-6. PubMed ID: 10374644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of anethole dithiolthione on human platelet aggregation.
    Selley ML; McGuiness JA; Bartlett MR; Ardlie NG
    Arzneimittelforschung; 1992 Mar; 42(3):318-21. PubMed ID: 1497692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influences of 3,4,5-trihydroxystibene-3-beta-mono-D-glucoside on rabbits' platelet aggregation and thromboxane B2 production in vitro].
    Shan CW; Yang SQ; He HD; Shao SL; Zhang PW
    Zhongguo Yao Li Xue Bao; 1990 Nov; 11(6):527-30. PubMed ID: 2130618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of nimodipine on platelet aggregation and the activity of enzymes in arachidonic acid metabolism.
    Li J; Wang Z
    Proc Chin Acad Med Sci Peking Union Med Coll; 1990; 5(1):47-50. PubMed ID: 2115166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of neferine on platelet aggregation in rabbits].
    Yu J; Hu WS
    Yao Xue Xue Bao; 1997; 32(1):1-4. PubMed ID: 11243209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of protopine on rabbit platelet function].
    Ma GY; Zhang ZZ; Chen ZH
    Zhongguo Yao Li Xue Bao; 1994 Jul; 15(4):367-71. PubMed ID: 7801784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro antiplatelet profiles of the new thromboxane synthetase inhibitor sodium 2-(1-imidazolylmethyl)-4,5-dihydrobenzo[b]thiophene-6-carboxylate.
    Asai F; Ito T; Ushiyama S; Matsuda K; Oshima T
    Arzneimittelforschung; 1991 May; 41(5):506-10. PubMed ID: 1898421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of 3-n-butylphthalide on thrombosis formation and platelet function in rats].
    Xu HL; Feng YP
    Yao Xue Xue Bao; 2001 May; 36(5):329-33. PubMed ID: 12584852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
    Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
    Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
    Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
    Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of platelet aggregation by polyaspartoyl L-arginine and its mechanism.
    Wang YY; Tang ZY; Dong M; Liu XY; Peng SQ
    Acta Pharmacol Sin; 2004 Apr; 25(4):469-73. PubMed ID: 15066215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of 764-3 on platelet aggregation and the activity of enzymes in arachidonic acid metabolism].
    Wang Z; Zhang H; You H
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Apr; 16(2):140-3. PubMed ID: 7987942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of CI-930, a novel phosphodiesterase III inhibitor, on platelet aggregation and arachidonic acid metabolism.
    Chen XS; Zeng HW; Jiang YY; Wan WQ; Long K
    Zhongguo Yao Li Xue Bao; 1990 Jul; 11(4):338-43. PubMed ID: 1966575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.